Children with hematologic malignancies continue to exhibit increased IPD risk despite an overall decline in pediatric IPD after the introduction of the PCV13 vaccine.

The US FDA has published more than 200 complete response letters sent as replies to drug and biological product applications.

Of patients experiencing Lyme Disease symptoms, only 35% follow up with a clinician, according to a recent study.

Nurse practitioners should learn how to mitigate language and cultural barriers to provide culturally competent care to Asian American patients. Nurse practitioners (NPs) form the key to providing ...

Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.

The Trump administration's recent travel and visa restrictions have left some hospitals in the United States without essential staff.

A new malaria treatment has been approved for newborns and infants under 11 pounds, filling a major gap in care.

Measles cases in the United States have reached their highest level in 25 years, with more than 1,270 confirmed cases this year.

The National Institutes of Health announced it will put a limit on publisher fees for publicly funded research by Fiscal Year 2026.

The prevalence of long COVID-typical symptom clusters was relatively high among a cohort of adults 2 years after initial COVID-19 infection.

The FDA has approved Tyzavan, a novel ready-to-infuse, room temperature stable formulation of vancomycin, for the treatment of various bacterial infections.

There has been nationwide total of 1,267 confirmed cases of measles this year, with Kentucky being the latest state to announce an outbreak.